XML 57 R25.htm IDEA: XBRL DOCUMENT
v3.24.0.1

Note 9 - Capital Stock and Reserve (Tables) | 9 Months Ended
--- | ---
Dec. 31, 2023
Statement Line Items [Line Items] |
Disclosure of number and weighted average exercise prices of share options [text block] |
Expiry Date |  | Exercise Price |  |  | Balance March 31, 2023 |  |  | Granted |  |  | Exercised |  |  | Forfeited/ Expired |  |  | Balance December 31, 2023 |  |  | Exercisable |
March 1, 2024 |  | $ | 16.50 |  |  |  | 15,000 |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 15,000 |  |  |  | 15,000 |
November 14, 2024 |  | $ | 3.65 |  |  |  | - |  |  |  | 36,000 |  |  |  | (36,000 | ) |  |  | - |  |  |  | - |  |  |  | - |
March 8, 2025 |  | $ | 15.50 |  |  |  | 4,000 |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 4,000 |  |  |  | 4,000 |
September 2, 2025 |  | $ | 12.75 |  |  |  | 20,000 |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 20,000 |  |  |  | 20,000 |
September 6, 2025 |  | $ | 13.75 |  |  |  | 8,000 |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 8,000 |  |  |  | 8,000 |
November 20, 2025 |  | $ | 4.00 |  |  |  | 6,000 |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 6,000 |  |  |  | 6,000 |
December 2, 2025 |  | $ | 9.00 |  |  |  | 62,000 |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 62,000 |  |  |  | 62,000 |
December 13, 2025 |  | $ | 9.50 |  |  |  | 31,000 |  |  |  | - |  |  |  | - |  |  |  | (10,000 | ) |  |  | 21,000 |  |  |  | 21,000 |
January 15, 2026 |  | $ | 7.25 |  |  |  | 35,300 |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 35,300 |  |  |  | 35,300 |
August 25, 2026 |  | $ | 5.65 |  |  |  | - |  |  |  | 17,500 |  |  |  | - |  |  |  | - |  |  |  | 17,500 |  |  |  | 17,500 |
September 6, 2026 |  | $ | 6.60 |  |  |  | - |  |  |  | 40,000 |  |  |  | - |  |  |  | - |  |  |  | 40,000 |  |  |  | 40,000 |
November 1, 2026 |  | $ | 7.50 |  |  |  | 10,000 |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 10,000 |  |  |  | 10,000 |
December 4, 2026 |  | $ | 5.47 |  |  |  | - |  |  |  | 20,000 |  |  |  | - |  |  |  | - |  |  |  | 20,000 |  |  |  | 20,000 |
February 16, 2027 |  | $ | 17.50 |  |  |  | 20,000 |  |  |  | - |  |  |  | - |  |  |  | (20,000 | ) |  |  | - |  |  |  | - |
September 6, 2028 |  | $ | 6.60 |  |  |  | - |  |  |  | 85,000 |  |  |  | - |  |  |  | - |  |  |  | 85,000 |  |  |  | 85,000 |
Total |  |  |  |  |  |  | 211,300 |  |  |  | 198,500 |  |  |  | (36,000 | ) |  |  | (30,000 | ) |  |  | 343,800 |  |  |  | 343,800 |
Weighted average exercise price |  |  | $ | 10.81 |  |  | $ | 5.87 |  |  | $ | 3.65 |  |  | $ | 14.83 |  |  | $ | 8.46 |  |  | $ | 8.46 |
Weighted average remaining life (years) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 2.61 |  |  |  |  |
Expiry Date |  | Exercise Price |  |  | Balance March 31, 2022 |  |  | Granted |  |  | Exercised |  |  | Forfeited/ Expired |  |  | Balance March 31, 2023 |  |  | Exercisable |
January 4, 2023 |  | $ | 14.25 |  |  |  | 105,000 |  |  |  | - |  |  |  | - |  |  |  | (105,000 | ) |  |  | - |  |  |  | - |
March 1, 2024 |  | $ | 16.50 |  |  |  | 15,000 |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 15,000 |  |  |  | 15,000 |
March 8, 2025 |  | $ | 15.50 |  |  |  | 4,000 |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 4,000 |  |  |  | 4,000 |
September 2, 2025 |  | $ | 12.75 |  |  |  | - |  |  |  | 20,000 |  |  |  | - |  |  |  | - |  |  |  | 20,000 |  |  |  | 20,000 |
September 6, 2025 |  | $ | 13.75 |  |  |  | - |  |  |  | 8,000 |  |  |  | - |  |  |  | - |  |  |  | 8,000 |  |  |  | 8,000 |
November 20, 2025 |  | $ | 4.00 |  |  |  | 8,000 |  |  |  | - |  |  |  | (2,000 | ) |  |  | - |  |  |  | 6,000 |  |  |  | 6,000 |
December 2, 2025 |  | $ | 9.00 |  |  |  | - |  |  |  | 62,000 |  |  |  | - |  |  |  | - |  |  |  | 62,000 |  |  |  | 62,000 |
December 13, 2025 |  | $ | 9.50 |  |  |  | - |  |  |  | 31,000 |  |  |  | - |  |  |  | - |  |  |  | 31,000 |  |  |  | 31,000 |
January 15, 2026 |  | $ | 7.25 |  |  |  | 41,300 |  |  |  | - |  |  |  | (6,000 | ) |  |  | - |  |  |  | 35,300 |  |  |  | 35,300 |
October 21, 2026 |  | $ | 5.25 |  |  |  | 5,000 |  |  |  | - |  |  |  | (5,000 | ) |  |  | - |  |  |  | - |  |  |  | - |
November 1, 2026 |  | $ | 7.50 |  |  |  | 10,000 |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 10,000 |  |  |  | 10,000 |
December 3, 2026 |  | $ | 12.50 |  |  |  | 6,000 |  |  |  | - |  |  |  | - |  |  |  | (6,000 | ) |  |  | - |  |  |  | - |
January 17, 2027 |  | $ | 20.50 |  |  |  | 10,000 |  |  |  | - |  |  |  | - |  |  |  | (10,000 | ) |  |  | - |  |  |  | - |
February 16, 2027 |  | $ | 17.50 |  |  |  | 20,000 |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 20,000 |  |  |  | 20,000 |
Total |  |  |  |  |  |  | 224,300 |  |  |  | 121,000 |  |  |  | (13,000 | ) |  |  | (121,000 | ) |  |  | 211,300 |  |  |  | 211,300 |
Weighted average exercise price |  |  | $ | 12.88 |  |  | $ | 10.06 |  |  | $ | 5.98 |  |  | $ | 14.67 |  |  | $ | 10.81 |  |  | $ | 10.81 |
Weighted average remaining life (years) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 2.57 |  |  |  |  |
Expiry Date |  | Exercise Price |  |  | Balance March 31, 2023 |  |  | Granted |  |  | Exercised |  |  | Forfeited/ Expired |  |  | Balance December 31, 2023 |  |  | Exercisable |
March 31, 2024 |  | $ | 14.25 |  |  |  | 15,000 |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 15,000 |  |  |  | - |
Total |  |  |  |  |  |  | 15,000 |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 15,000 |  |  |  | - |
Weighted average exercise price |  |  | $ | 14.25 |  |  |  | - |  |  |  | - |  |  |  | - |  |  | $ | 14.25 |  |  |  | - |
Weighted average remaining life (years) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0.75 |  |  |  |  |
Expiry Date |  | Exercise Price |  |  | Balance March 31, 2022 |  |  | Granted |  |  | Exercised |  |  | Forfeited/ Expired |  |  | Balance March 31, 2023 |  |  | Exercisable |
March 31, 2024 |  | $ | 14.25 |  |  |  | 15,000 |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 15,000 |  |  |  | - |
Total |  |  |  |  |  |  | 15,000 |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 15,000 |  |  |  | - |
Weighted average exercise price |  |  | $ | 14.25 |  |  |  | - |  |  |  | - |  |  |  | - |  |  | $ | 14.25 |  |  |  | - |
Weighted average remaining life (years) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1.25 |  |  |  |  |
Disclosure of indirect measurement of fair value of goods or services received, share options granted during period [text block] |
|  | Weighted Average for the period ended December 31, 2023 |  |  | Weighted Average for the year ended March 31, 2023 |
Fair value per option |  | $ | 4.07 |  |  | $ | 6.00 |
Exercise price |  | $ | 5.87 |  |  | $ | 11.00 |
Expected life (years) |  |  | 3.50 |  |  |  | 3.00 |
Interest rate |  |  | 4.22 | % |  |  | 3.49 | %
Annualized volatility (based on historical volatility) |  |  | 109 | % |  |  | 118 | %
Dividend yield |  |  | 0.00 | % |  |  | 0.00 | %
Disclosure of detailed information about warrant transactions [text block] |
Expiry Date |  | Exercise Price |  |  | Balance March 31, 2023 |  |  | Granted |  |  | Exercised |  |  | Cancelled/ Expired |  |  | Balance December 31, 2023 |
December 2, 2023 |  | $ | 6.50 |  |  |  | 24,000 |  |  |  | - |  |  |  | - |  |  |  | (24,000 | ) |  |  | - |
August 24, 2028 |  | USD$6.25 |  |  |  | - |  |  |  | 800,000 |  |  |  | - |  |  |  | - |  |  |  | 800,000 |
Total |  |  |  |  |  |  | 24,000 |  |  |  | 800,000 |  |  |  | - |  |  |  | (24,000 | ) |  |  | 800,000 |
Weighted average exercise price |  |  | $ | 6.50 |  |  | USD$6.25 |  |  |  | - |  |  | $ | 6.50 |  |  | USD$6.25 |
Weighted average remaining life (years) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 4.65 |
Expiry Date |  | Exercise Price |  |  | Balance March 31, 2022 |  |  | Granted |  |  | Exercised |  |  | Cancelled/ Expired |  |  | Balance March 31, 2023 |
August 28, 2022 |  | $ | 3.75 |  |  |  | 53,778 |  |  |  | - |  |  |  | (53,778 | ) |  |  | - |  |  |  | - |
August 28, 2022 |  | $ | 5.00 |  |  |  | 121,600 |  |  |  | - |  |  |  | (121,600 | ) |  |  | - |  |  |  | - |
October 29, 2022 |  | $ | 12.50 |  |  |  | 36,166 |  |  |  | - |  |  |  | (3,572 | ) |  |  | (32,594 | ) |  |  | - |
December 15, 2022 |  | $ | 5.00 |  |  |  | 22,000 |  |  |  | - |  |  |  | (10,000 | ) |  |  | (12,000 | ) |  |  | - |
December 2, 2023 |  | $ | 6.50 |  |  |  | 47,800 |  |  |  | - |  |  |  | (23,800 | ) |  |  | - |  |  |  | 24,000 |
Total |  |  |  |  |  |  | 281,344 |  |  |  | - |  |  |  | (212,750 | ) |  |  | (44,594 | ) |  |  | 24,000 |
Weighted average exercise price |  |  | $ | 5.98 |  |  |  | - |  |  | $ | 4.98 |  |  | $ | 10.48 |  |  | $ | 6.50 |
Weighted average remaining life (years) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0.67 |
Expiry Date |  | Exercise Price |  |  | Balance March 31, 2023 |  |  | Granted |  |  | Exercised |  |  | Cancelled/ Expired |  |  | Balance December 31, 2023 |
July 19, 2024 |  | $ | 10.00 |  |  |  | 5,765 |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 5,765 |
August 21, 2028 |  | USD$6.25 |  |  |  | - |  |  |  | 40,000 |  |  |  | - |  |  |  | - |  |  |  | 40,000 |
Total |  |  |  |  |  |  | 5,765 |  |  |  | 40,000 |  |  |  | - |  |  |  | - |  |  |  | 45,765 |
Weighted average exercise price |  |  | $ | 10.00 |  |  | USD$6.25 |  |  |  | - |  |  |  | - |  |  |  | - |
Weighted average remaining life (years) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 4.13 |
Expiry Date |  | Exercise Price |  |  | Balance March 31, 2022 |  |  | Granted |  |  | Exercised |  |  | Cancelled/ Expired |  |  | Balance March 31, 2023 |
July 19, 2024 |  | $ | 10.00 |  |  |  | - |  |  |  | 5,765 |  |  |  | - |  |  |  | - |  |  |  | 5,765 |
Total |  |  |  |  |  |  | - |  |  |  | 5,765 |  |  |  | - |  |  |  | - |  |  |  | 5,765 |
Weighted average exercise price |  |  |  | - |  |  | $ | 10.00 |  |  |  | - |  |  |  | - |  |  | $ | 10.00 |
Weighted average remaining life (years) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1.30 |
Agent warrants [member] |
Statement Line Items [Line Items] |
Disclosure of indirect measurement of fair value of warrants granted during period [text block] |
|  | For the period ended December 31, 2023 |  |  | For the year ended March 31, 2023 |
Fair value per agents warrant |  | $ | 5.67 |  |  | $ | 3.81 |
Exercise price |  | USD$6.25 |  |  | $ | 10.00 |
Expected life (years) |  |  | 5.00 |  |  |  | 2.00 |
Interest rate |  |  | 4.14 | % |  |  | 3.30 | %
Annualized volatility (based on historical volatility) |  |  | 113 | % |  |  | 120 | %

X
- Definition The disclosure of detailed information about warrant transactions. + References No definition available. + Details
Name: | fmst_DisclosureOfDetailedInformationAboutWarrantTransactionsTextBlock
Namespace Prefix: | fmst_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of information about indirect, by reference to the fair value of the warrant granted, measurement of the fair value of goods or services received as consideration for the entity's share options. + References No definition available. + Details
Name: | fmst_DisclosureOfIndirectMeasurementOfFairValueOfWarrantsGrantedDuringPeriodTextBlock
Namespace Prefix: | fmst_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | fmst_Statement1LineItems
Namespace Prefix: | fmst_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of information about indirect, by reference to the fair value of the equity instruments granted, measurement of the fair value of goods or services received as consideration for the entity's share options. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2023-01-01 -Paragraph 47 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_47_a&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of the number and weighted average exercise prices of share options. [Refer: Weighted average [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2023-01-01 -Paragraph 45 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | ifrs-full_ClassesOfEntitysOwnEquityInstrumentsAxis=fmst_AgentWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |